O&G JC106: Climacteric Symptoms: Menopause And Related Illness, Amenorrhoea Flashcards

1
Q

Hypothalamic-Pituitary-Ovarian axis (HPO axis)

A

Hypothalamus –> GnRH
–> Pituitary –> FSH, LH
–> Ovary –> Estrogen (-ve feedback)
–>
1. Growth of dominant follicle in the beginning of Follicular phase
2. Thickening of endometrial lining

LH surge
–> Ovulation
–> ↑ Progesterone level

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Amenorrhoea

A

Definition:
- Absence of menstrual period in a woman of reproductive age
- A symptom, NOT diagnosis (∵ many causes)
- Primary vs Secondary

Primary amenorrhoea:
- Absence of menstruation by age **16 (if presence of normal secondary sexual characteristics)
(Investigate by age **
14 if no secondary sexual characteristics: indicate low Estrogen level)
—> Congenital / Genetic abnormalities
—> Disturbance of normal endocrinological events of puberty
—> ALL causes of Secondary amenorrhoea can also present as primary amenorrhoea if occur early enough

Secondary amenorrhoea:
- Absence of menstruation for ***6 months in a woman who has menstruated before

(Oligomenorrhoea:
- Have period but Cycle length >35 days
- Investigations / Management similar to Secondary amenorrhoea ∵ lots of overlap)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of Amenorrhoea

A
  1. Physiological
    - Pre-pubertal
    - Pregnancy + Lactation
    - Post-menopausal
    - Contraceptives
  2. Pathological (in HPO axis)
    Endocrine:
    - Hypothalamus / CNS disorders
    - Pituitary disorders
    - Ovary disorders
    - Thyroid disorders (Hyper / Hypo)
    - Adrenal disorders (Tumour, Cushing’s, CAH)

Anatomical:
- Outflow tract obstruction
- Uterus disorders (e.g. absence of uterus)
- Endometrial damage (e.g. Asherman’s syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hypothalamus / CNS disorders

A

Not enough GnRH secreted
1. Functional hypothalamic amenorrhoea (CNS effect)
- weight loss
- over exercise
- stress
- eating disorders (e.g. anorexia nervosa)
- systemic illness

  1. ***Kallmann syndrome
    - congenital hypogonadotrophic hypogonadism (isolated GnRH deficiency) associated with anosmia
  2. Idiopathic hypogonadotrophic hypogonadism
  3. Tumours e.g. ***Craniopharyngioma
  4. Cranial irradiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pituitary disorders

A

Hyperprolactinaemia:
1. ***Prolactinoma
2. Non-functioning adenoma (stalk effect)
3. Other causes of Hyperprolactinaemia (prolactinoma may be a cause)

Hypopituitarism:
1. ***Sheehan’s syndrome
- follow severe post-partum haemorrhage (∵ severe hypotension –> severe hypovolaemia –> ischaemia + necrosis of pituitary –> hypopituitarism following delivery)
2. Iatrogenic: Surgery / RT

Other endocrinopathies:
1. Thyroid dysfunction (Hyper / Hypo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

***Causes of Hyperprolactinaemia (SpC O&G)

A
  1. ***Pregnancy, Lactation
  2. Stress (transient)
  3. ***Prolactinoma
  4. Other pituitary tumours, non-functioning “disconnection” tumour —> disrupt inhibitory influence of Dopamine on Prolactin
  5. ***Primary hypothyroidism
  6. Drug inhibiting Dopamine secretion
    - **Dopaminergic antagonist
    - Phenothiazine (+ Other Typical antipsychotics)
    - **
    Domperidone
    - ***Metoclopramide
    - Cimetidine
    - Methyldopa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ovary disorders

A
  1. Primary ovarian insufficiency (POI) (loss of function of ovaries ~ menopause; In contrast to PCOS (ovaries are actually working))
    - **Gonadal agenesis / dysgenesis
    —> ∵ chromosomal / non-chromosomal problems (e.g. **
    Turner syndrome / variant, **Fragile X premutation (but not full blown Fragile X))
    - **
    Iatrogenic
    —> Surgery: Bilateral oophorectomy for ovarian tumours
    —> RT to pelvis
    —> Chemotherapy
    - ***Autoimmune
    - Idiopathic
  2. Polycystic ovary syndrome (PCOS)
  3. Androgen-secreting ovarian tumour (rare)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Polycystic ovary syndrome (PCOS) (多囊卵巢綜合症)

A
  • Disorders of ovary (but ovaries are working vs Ovarian insufficiency)
  • Endocrine disturbance –> Oligo / Anovulation

Diagnosis (**Rotterdam criteria, 2 out of 3):
1. Oligo-anovulation
2. Clinical / Biochemical hyperandrogenism (e.g. hirsutism, ↑ acnes)
3. Sonographic features of polycystic ovaries (Follicle number per ovary **
>=20, each 2-9mm / Ovarian volume ***>=10ml, String of pearls sign) (ONE ovary is sufficient for definition)

Exclusion of other etiologies with similar clinical features:
- Thyroid disorders
- Hyperprolactinaemia
- POI
- Hypogonadotrophic hypogonadism
- **Non-classic CAH
- **
Cushing’s syndrome
- ***Adrenal tumours (androgen-secreting (self notes))
- etc.

Long-term health sequalae of PCOS:
1. **Metabolic syndrome (HT, DM, HL, CVS disease)
2. **
Infertility (∵ anovulation)
3. ***Endometrial hyperplasia / cancer (∵ unopposed estrogen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Outflow tract / Uterus disorders

A

End organs in which hypothalamic, pituitary, ovarian hormones act on
1. Outflow tract obstruction (at different levels, generally congenital –> primary amenorrhoea usually)
- **Cervical / Vaginal atresia
- **
Transverse vaginal septum
- **Imperforate hymen
S/S:
- **
Cyclical abdominal pain (∵ trapped period –> distension)
- **Pelvic mass
- **
Endometriosis (∵ backflow of period)

  1. Vagina / Uterus absence
  2. Endometrial destruction leading to obstruction
    - **TB endometritis
    - **
    Asherman’s syndrome (intrauterine adhesions following surgery e.g. suction, evacuation, myomectomy) –> causes problems e.g. infertility, amenorrhoea, recurrent miscarriage

(Congenital abnormality in Mullerian development (i.e. uterus):
- Isolated defect (absence / hypoplasia of uterus)
- Androgen insensitivity syndrome
- 5α-reductase deficiency

Congenital defect of Urogenital sinus development (i.e. outflow tract):
- Agenesis of lower vagina
- Imperforate hymen

Damage to endometrium:
- Asherman syndrome
- TB endometritis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Androgen insensitivity syndrome (AIS)

A

Androgen receptor mutation
- ***46XY (in a girl) (I.e. born a male, but phenotype girl)
- Androgen receptors resistant to androgens
- Testosterone: High-Normal / Slightly elevated male range
- Estradiol: Upper normal male range

S/S:
1. Primary amenorrhoea
2. Female external genitalia (∵ Non-virilisation of genitalia –> Female phenotype)
3. Undescended gonads
4. No axillary / pubic hair
5. Some breast development (∵ peripheral conversion of androgen –> estrogen)
6. Inguinal masses / hernia
7. Absent uterus (AMH: Anti-mullerian hormone)
8. Short vagina

Associated health problems:
1. Testicular malignancy
2. Hypoestrogenism (after gonadectomy)

Treatment:
1. HRT (after gonadectomy (remove testes))
2. Fertility: Child adoption
3. Sexuality: Vaginal dilation / reconstruction (let the male live as a female instead)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Summary of causes of Amenorrhoea

A

Primary amenorrhoea:
- MUST rule out:
1. Absence of uterus / outflow tract obstruction / disorders of sex development (AIS, Swyer syndrome)
2. All causes of secondary amenorrhoea (∵ can cause primary amenorrhoea if occurs before they have first ever period)

Secondary amenorrhoea:
- Women MUST have had:
1. Patent lower genital tract
2. Endometrium that is responsive to ovarian hormone stimulation
3. Ovaries that have responded to pituitary gonadotrophins
–> ∴ can rule out congenital causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

***History taking of Amenorrhoea

A
  1. Onset + Duration
  2. Previous menstruation (determine primary / secondary amenorrhoea)
  3. ***Pubertal development
    - growth spurt and age it occurred
    - development of pubic / axillary hair / breast
  4. ***Nutrition, Stress, Weight change, Excessive exercise
    - indicate hypothalamic cause
  5. ***Galactorrhoea, headache, visual disturbance
    - indicate hyperprolactinaemia / prolactinoma
  6. ***Menopausal symptoms
    - e.g. hot flushes / dryness –> indicate POI
  7. ***Thyroid symptoms
    - hyper / hypothyroidism
  8. ***Hyperandrogenic symptoms (e.g. Adrenal tumour, Androgen-secreting ovarian tumour, Cushing’s, PCOS)
    - e.g. ↑ acne, hirsutism, male pattern baldness
  9. Congenital symptoms
    - ***Anosmia (Kallmann syndrome)
  10. ***Anatomical symptoms
    - Cyclical abdominal pain
    - Urinary retention
  11. Past medical, surgical
    - previous OG history, cervical smear, fertility wish
    - previous chemo, RT, surgery (POI)
    - previous **
    ovarian surgery, dilatation, curettage (
    Asherman’s syndrome)
    - previous *PPH (
    Sheehan’s syndrome)
  12. Sexual history
    - ***pregnancy
  13. Drug history
    - long-term medications
    - ***contraceptives
  14. Social history
  15. Family history

Rmb: ALWAYS rule out ***pregnancy! (∵ commonest cause of amenorrhoea in reproductive age women!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

***Physical examination of Amenorrhoea

A
  1. Body height, weight, BMI (compare with previous BMI)
  2. ***Stigmata of chromosomal abnormality (Turner syndrome)
  3. ***Galactorrhoea, visual field
  4. ***Goitre, Thyroid signs
  5. **Cushingoid features / **Hirsutism / Virilisation (Ferriman-Gallwey hirsutism scoring system: 9 body areas most sensitive to androgen (score 0-4))
  6. ***Secondary sexual characteristics
  7. Abdominal mass
  8. Genital tract development / PR exam
    - clitoromegaly (sign of hyperandrogenism)
    - pubic hair distribution + maturity (Tanner stage for pubic hair)
    - swelling of introitus (outflow tract obstruction)
    - hymen
    - vaginal length
    - presence of cervix / uterus / ovaries
    - may be difficult to assess in patients not been sexually active –> inspect introitus, genitalia, imaging

Rmb: ALWAYS rule out ***pregnancy! (∵ commonest cause of amenorrhoea in reproductive age women!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

***Investigations of Amenorrhoea

A

1st line:
1. ***Pregnancy test (exclude pregnancy!!!)

  1. **Hormonal profile
    - **
    FSH, LH —> check HPO axis
    - **Estradiol —> check HPO axis
    - **
    Prolactin —> exclude hyperprolactinaemia
    - ***Testosterone —> (<5: PCOS, >5 more likely androgen-secreting tumour)
    - TFT —> exclude thyroid disorders
  2. **Progestogen challenge test (Provera withdrawal test) (通經藥)
    - give progestogen for 1 week
    –> withdrawal bleeding (+ve test) –> sufficient Estrogen in body resulting in sufficient endometrial thickness –> when progestogen withdrawn –> shedding of endometrium –> amenorrhoea is due to **
    Anovulation
    –> no withdrawal bleeding (-ve test) –> insufficient Estrogen in body (∴ thin lining) or Anatomical problems
  3. ***USG pelvis
    - Uterus / Ovarian morphology (e.g. PCOS) / presence / absence

Other investigations (depending on cause)
5. Hormonal
- **Androgens (SHBG, 17-OH progesterone –> CAH) (if significant virilisation / hirsutism)
- **
E+P withdrawal test (when -ve progestogen challenge test –> if now +ve (有翻bleeding) –> indicate low endogenous Estrogen level rather than Anatomical problems)
- Dynamic tests: e.g. GnRH test for pituitary function

  1. Genetic
    - ***Karyotype (Primary amenorrhoea, POI) (e.g. Turner syndrome)
    (if suspect primary amenorrhoea / disorders of sex differentiation ∵ ambiguous genitalia, absent uterus)
    - Fragile X premutation (POI)
  2. Radiological
    - 3D USG pelvis / MRI / USG renal tract (∵ common embryonal origin as pelvic organ –> examine whether there is co-existing congenital urinary tract problem) –> examine congenital uterine abnormality
    - **Pituitary imaging
    - **
    CT adrenal glands
  3. Visual field by perimetry
  4. Laparoscopy / Hysteroscopy
    - if suspect congenital uterine problem
  5. Autoimmune screening (for POI)
    - Anti-thyroid Ab (Anti-TPO)
    - Anti-adrenal Ab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

***Diagnostic approach to Amenorrhoea

A

Presented with amenorrhoea
–> History + P/E + **Pregnancy test
–> Negative
–> **
Hormonal profile (FSH, Estrogen, Prolactin, TFT, **Provera (Progestogen) withdrawal test)
–>
1. FSH ↑ –> **
POI –> Karyotype / Fragile X / Autoimmune functions

  1. FSH ↓ –> ***hypogonadotrophic hypogonadism –> MRI to exclude hypothalamic / pituitary tumour
  2. FSH normal
    –> Withdrawal +ve –> Pelvic USG to rule out **PCOS
    –> Withdrawal -ve –> **
    Endometrial / Outflow tract problems
  3. Prolactin ↑ –> MRI to exclude ***pituitary tumour
  4. TFT abnormal –> Refer physician
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Anovulation

A

WHO classification:
Class 1: Hypogonadotrophic hypogonadism (hypothalamic / pituitary problems)
- ↓ FSH / LH
- ↓ E2

Class 2: Normogonadotrophic anovulation (e.g. ***PCOS)
- Normal FSH / LH
- Normal E2

Class 3: Hypergonadotrophic hypogonadism (e.g. ***POI)
- ↑ FSH / LH
- ↓ E2

17
Q

Principles of treatment of Amenorrhoea

A

Rmb: Amenorrhoea is a symptom! (NOT diagnosis)
1. Need to look for underlying cause + treat accordingly
2. Rmb **physiological causes e.g. Pregnancy
3. **
Hormone replacement?
4. Treat **sexuality issues?
5. Treat **
fertility issues?
6. Prevent + treat associated ***health problems

18
Q

Treatment of Hypogonadotrophic hypogonadism

A
  1. Environmental causes
    - lifestyle (avoid stress, eating disorder, significant weight loss, over exercise)
    - reassurance + observe
    - psychological treatment
  2. Primary / Secondary amenorrhoea without obvious external cause
    - **Pituitary imaging
    - **
    GnRH stimulation test
  3. Visual field perimetry
    - for hypothalamic / pituitary lesions
  4. ***Neurosurgical treatment
    - for hypothalamic / pituitary lesions
  5. Induction of puberty in Primary amenorrhoea
    - Estrogen (start slow, go slow)
  6. Protect bone if after puberty / induction of puberty
    - Maintenance ***HRT (Estrogen + Progestogen) (except for transient secondary causes)
  7. Fertility treatment
    - ***Gonadotrophin injections to induce ovulation
19
Q

***Management of Polycystic Ovary Syndrome (PCOS)

A
  1. Weight reduction (Diet control + Exercise)
    - ∵ Often obesity associated
    - Beneficial in help restoring ovulation + improve metabolic disorder
  2. Menstrual regulation (∵ Oligo/Anovulation –> No corpus luteum –> ↓ Progesterone –> unopposed Estrogen –> ↑ risk of endometrial hyperplasia / CA)
    - **Cyclical progestogen (given for 1 week every 2-3 months) –> induce **withdrawal bleeding + **endometrial protection
    - **
    COC pills -> induce **normal menstruation + **contraceptive effect + ***endometrial protection
  3. Hirsutism
    - COC pills (risk of thromboembolism esp. overweight women)
    - Cosmetic measures (e.g. laser therapy, shaving)
    - **
    Anti-estrogens (
    *Anti-androgen?? (self notes)) (Spironolactone)
  4. Fertility
    - Ovulation induction
    —> 1st line: **Letrozole (Aromatase inhibitor) / **Clomiphene citrate
    —> 2nd line: **Gonadotrophin / **Surgical (e.g. laparoscopic ovarian **drilling)
    —> 3rd line: **
    IVF
    - Weight reduction
  5. Metabolic disorder in the long-term
    - Healthy lifestyle
    - Monitor BMI, BP, **OGTT, **Lipid profile

(From JC111:
- Letrozole: Aromatase inhibitor —> ↓ Estrogen from Testosterone conversion —> ↓ suppression of FSH —> allow maturation of follicle)
- Clomiphene: Anti-estrogen acting at Hypothalamus —> ↓ -ve feedback (self notes) —> ↑ GnRH pulse frequency (wiki) —> ↑ FSH, LH —> ↑ Ovulation
- Gonadotrophin: FSH+LH / Recombinant FSH injections, Acts directly on ovaries + very effective, High risk of ***OHSS)

20
Q

Premature Ovarian Insufficiency (POI)

A

Diagnosis:
- ***↑ FSH >25 twice (>=4 weeks apart in age <40)

Investigations:
1. Karyotype (Turner syndrome)
2. Fragile X premutation
3. Autoimmune tests
- Anti-thyroid Ab (Anti-TPO)
- Anti-adrenal Ab
4. DXA scan
- look for osteoporosis (∵ higher risk)

Treatment:
1. Induction of puberty if Primary amenorrhoea
- ***Estrogen

  1. Maintenance **HRT (Estrogen + Progesterone) for bone protection (till **51)
  2. Fertility treatment
    - ***Oocyte donation
    - Adoption
21
Q

Other endocrinopathies

A
  1. ***Thyroid disorder
  2. ***Hyperprolactinaemia
    - Dopamine agonists e.g. Bromocriptine, Cabergoline
    - Neurosurgery (rarely)
  3. ***Congenital adrenal hyperplasia (CAH)
22
Q

Anatomical anomalies

A

Diagnosis:
- 3D USG
- MRI pelvis
- ***Laparoscopy / Hysteroscopy
–> Identify location / types of anomaly –> treat accordingly

Investigations:
1. Assess associated renal tract anomalies by imaging

Treatment:
1. **Surgical correction of congenital anomalies / outflow tract obstruction
- Hymenotomy / Cruciate incision for imperforate hymen
2. Treat fertility / sexual issues depending on cause
3. **
Vaginal dilation (if vaginal atresia) for sexual life

23
Q

Climacteric and Menopause

A

Climacteric:
- years of waning ovarian function
- a period of time which marks transition from reproductive to non-reproductive state

Menopause:
- a specific time-point / event (**final menstrual period)
- permanent cessation of ovarian function and fertility
- diagnosed retrospectively after cessation of menses for **
12 months in a previously cycling woman

Perimenopause:
- period beginning with the first clinical, biological, endocrinological features of approaching menopause
- ends 12 months after final menstrual period
- may last for several years

24
Q

Clinical types of menopause

A
  1. Natural menopause
    - clinically diagnosed in retrospect following spontaneous amenorrhoea for 12 months
    - without other obvious pathological / physiological causes
    - mean age 51 yo
  2. Artificial / Induced menopause
    - sudden termination of menstrual life due to surgery / RT / chemo
  3. Premature ovarian insufficiency
    - loss of ovarian function before 40 yo
25
Q

Endocrine changes at menopause

A

↓ Ovarian follicle number
1. ***↓ Estradiol

  1. ↓ Inhibins
    –> Loss of -ve feedback
    –> ↑ FSH + LH
    –> ↑ LH stimulates ovarian stroma to produce **androgens
    –> peripheral conversion to **
    estrone
26
Q

Climacteric symptoms

A

Associated with low estradiol level

  1. Vasomotor symptoms
    - **hot flushes
    - **
    sweating
    - palpitation
    - dizziness
  2. Psychological symptoms
    - **loss of energy and drive
    - loss of concentration
    - **
    irritability
    - anxiety
    - depression
    - mood fluctuations
    - ***sleep disturbances
  3. Sexual dysfunction
    - **Dyspareunia (∵ low estrogen –> atrophic changes)
    - **
    ↓ Libido

Can also be multi-factorial (apart from menopause) –> Bio-psycho-social factors

  1. Urogenital atrophy
    Vaginal
    - ***dryness
    - burning
    - pruritus
    - dyspareunia
    - prolapse

Urinary
- urgency
- ***frequency
- dysuria
- UTI
- incontinence
- voiding difficulties

27
Q

Long-term health conditions in Post-menopause

A
  1. ***CVS disease
    - incidence ↑ after menopause
    - ∵ estrogen probably protective to vasculature + favourable effect on lipid profile
  2. ***Osteoporosis
    - estrogen deficiency –> bone loss
    - postmenopausal osteoporosis an important risk factor for fracture (+ loss in muscle mass –> weakness –> instability)
  3. Musculoskeletal
    - laxity of soft tissues + ↓ muscle strength
    - backache + joint pain
  4. Dementia + cognitive decline
28
Q

Osteoporosis

A

Skeletal disorder characterised by compromised bone strength predisposing a person to ↑ risk of fracture

Bone strength determined by:
1. Bone density
2. Bone quality

WHO criteria:
Normal: BMD <1 SD (below young adult mean for women)
Low bone mass: 1-2.5 SD
Osteoporosis: ***>2.5 SD
Severe osteoporosis: >2.5 SD + presence of >=1 fragility fractures

Fracture risk assessment + clinical management:
- FRAX tool: take into account other risk factors

29
Q

Diagnosis of menopause

A
  • ***Clinical diagnosis
  • Retrospective diagnosis
  • Healthy women >45 yo with amenorrhoea for ***12 months
  • No adequate biological markers
    –> **FSH ↑ some years before menopause
    –> High FSH may be **
    supportive in special circumstances (2 FSH test 6-8 weeks apart, persistently high confirm menopause (SpC FM))
30
Q

Management principles of Menopause

A
  1. Holistic bio-psycho-social approach for the general health of a post-menopausal woman
  2. Management of menopausal symptoms
  3. Prevention of chronic health conditions

Health considerations:
1. **Bone health
2. **
CVS risk assessment + management
3. Smoking cessation
4. Alcohol use moderation
5. Cancer screening + prevention

31
Q

Management of Menopause

A
  1. Lifestyle modification (to reduce hot flushes)
    - **air conditioning
    - dressing in layers
    - **
    avoid alcohol / spicy food
    - reducing obesity
    - ***reducing stress
  2. **HRT
    - effective for treatment of severe climacteric symptoms + improve QOL
    - notes other psychosocial issues
    - prevent / delay **
    bone loss, ↓ both vertebral + non-vertebral fractures
    - **topical estrogen for **atrophic symptoms
  3. Non-hormonal treatments
    Vasomotor symptoms:
  4. ***Clonidine
  5. ***Gabapentin
  6. Relaxation / lifestyle modifications

Mood symptoms:
1. ***Psychological therapy
2. Anti-depressants

Vaginal atrophy:
1. Lubricants for intercourse
2. ***Moisturisers

Osteoporosis:
1. Lifestyle e.g. Ca, Vit D, weight bearing exercise, avoid smoking / excessive alcohol + caffeine
2. SERM e.g. Raloxifene
3. ***Bisphosphonates
4. RANK-L inhibitor e.g. Denosumab

CVS health:
1. Lifestyle e.g. exercise, avoid smoking
2. ***Control of predisposing factors e.g. HT, HL, DM, obesity

32
Q

HRT regimens

A

Without uterus: Estrogen alone

With uterus: Estrogen + **Progesterone
- prevent endometrial hyperplasia / CA from unopposed estrogen
1. **
Cyclical
- Estrogen daily –> add Progesterone for 12-14 days per cycle for scheduled withdrawal bleeding
- Novofem, Femoston (SpC FM)

  1. **Continuous
    - Daily administration of Estrogen + Progestin (web)
    - Non-bleeding regimen
    - more suitable for women **
    >2 years of menopause
    - Premique, Activella, Kliogest (SpC FM)
  2. Tibolone
    - synthetic compound
    - converted to metabolites with estrogenic + progestogenic + some androgenic properties
33
Q

Types of HRT

A
  1. Estrogen type
    - Natural estrogen preferred e.g. ***17β-estradiol (Estrofem), conjugated equine estrogens (Premarin)

Preparations:
- **Oral
- **
Gel
- Transdermal patch (not available in HK)
- Implant (not available in HK)
- Vaginal ring (not available in HK)

  1. Progestogen type (**still need to take estrogen as well!!!)
    - **
    Oral
    - ***Mirena IUCD (levonogestrel-releasing intrauterine system)
  2. Phytoestrogens
    - Evidence conflicting
    - Limited data on role + safety in long-term post-menopausal health
    - Beware of unregulated preparations
34
Q

Principles of prescribing HRT

A
  1. **Lowest possible dose for **shortest possible duration for symptom relief
  2. No universal rule, tailored to individual’s condition and needs
  3. Special situation: POI
    - HRT till ***51
    - no ↑ CA breast risk than general population
35
Q

Risks of HRT

A
  1. ***CA breast
  2. ***Venous thromboembolism
  3. ***Stroke
  4. Gallbladder disease
    (5. CHD (some data suggestive benefits in CHD prevention if administered before 60 / within 10 years of menopause))

but no ↑ long-term risks (except stroke) on women without uterus on estrogen-only HRT

CI:
1. **Severe liver disease
2. **
Cerebral vascular disease
3. **DVT, embolism
4. **
Estrogen-dependent tumours e.g. breast, uterus
5. Undiagnosed uterine bleeding

36
Q

Monitoring of HRT

A
  1. Annual monitoring for continued need
  2. Well-women check-up as usual
  3. SE: breast tenderness, fluid retention, bloating, nausea, headache, irregular bleeding –> usually transient
  4. Bleeding pattern
    - report ***unscheduled bleeding promptly if occur after 3 months
  5. Cessation
    - tapering vs abrupt stop –> no proven difference
    - ***symptom recurrence
37
Q

HRT vs COC (SpC OG)

A

Both suitable for replacement of hormone

HRT:
- Dosage of estrogen, progesterone mimic endogenous level —> No contraceptive effect

COC:
- Dosage of estrogen, progesterone higher than endogenous level —> Contraceptive effect